Sensex, Nifty Set To Fall; RIL, Cipla, Ultratech Cement, M&M, Pharma Stocks In Focus

Alkem Lab: Macquarie initiates coverage of the stock with ‘underperform’; target price set at Rs 2,475, an implied return of 15%.

Ipca Lab: Macquarie initiates coverage of the stock with ‘underperform’, target price set at Rs 785, an implied downside of 14%.

Zydus Lifesciences: Macquarie initiates coverage of the stock with ‘underperform’, price target set at Rs 315, an implied downside of 18%.

Aurobindo Pharma: Macquarie initiates coverage of the stock with ‘underperform’, price target set at Rs 475, an implied return of -14%.

Cipla: Macquarie reinstated coverage with ‘outperform’, target price set at Rs 1,205, an implied upside of 18%.

Dr. Reddy’s: Macquarie reinstated coverage with ‘outperform’, target price set at Rs 4,805, an implied upside of 14%

Lupin: Macquarie reinstated coverage with ‘outperform’, target price set at Rs 790, an implied upside of 21%

Sun Pharma: Macquarie reinstated coverage with ‘outperform’, target price set at Rs 1,100, a return potential of 25%.